Originated by Research Vault Group, which attests it authorized this test as the brand of record.
Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.
Source records pending; released under documented administrator review
Expected Source records · acceptance Documented administrator review · unit source provenance
Source: Documented source-record review
Source records pending; released under documented administrator review
Source records pending; released under documented administrator review
Expected Source records · acceptance Documented administrator review · unit source provenance
Source: Documented source-record review
Source records pending; released under documented administrator review
More views of Vial A
| Test | Specification | Result | Verdict |
|---|---|---|---|
research screen | Specificationsample response within 402.11 m/z ±1.00 Da (inclusive 401.11–403.11 m/z) · natural copper isotope envelope and same-run matched-standard comparison confirmed · 402.11 m/z for [L+Cu−H]+ (published literature value, used as the published-literature comparator; not USP or FDA text and not a formula-derived mass), source https://doi.org/10.3390/molecules28186724 | Result402.03 m/z; published-literature comparator difference −0.08 Da | PASS |
validated in house | Specification≥ 99.25 area % | Result99.3% | PASS |
research screen | Specificationevery vial within ±10% of 50 mg | ResultVial A: 52.82 mg | PASS |
research screen | SpecificationRapid PCR screen | ResultTarget DNA not detected | PASS |
research screen | Specificationno fentanyl or analog at or above 1 ng/mg | Resultnone detected | PASS |
Results relate only to the item or portion tested. Unless sampling was performed or witnessed by Axiom Analytics, the laboratory does not attest that the submitted sample represents the wider lot or batch. A PASS designation means only that the reported result met the specification shown. It does not establish safety, efficacy, regulatory approval, legality, or suitability for human or animal use.
All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.
Where physical instrument analysis is performed, it takes place within Axiom Analytics' laboratory network, allocated at Axiom's discretion based on method, capacity, and order volume. Axiom Analytics performs sample accession, chain of custody, analytical oversight, and data review, and issues and is responsible for this certificate. Where analysis is subcontracted, the method is performed within the partner laboratory's published ISO/IEC 17025 scope of accreditation for that method, not merely at a laboratory holding ISO/IEC 17025 accreditation. Axiom Analytics does not itself currently hold ISO/IEC 17025 accreditation. The method-validation status of each reported result is identified beside that result. Partner laboratory identities are not disclosed: where samples are analyzed under double-blind conditions, they are identified only by an internal lot ID.
To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.
